RAFAEL HOLDINGS, INC. Other Investments and Securities, at Cost
RAFAEL HOLDINGS, INC. (RFL) had Other Investments and Securities, at Cost of $100.00 thousand as of 2023-04-30, per its 10-Q filed 2023-06-13.
Discontinued › Balance Sheet › Assets
us-gaap:OtherInvestmentsAndSecuritiesAtCost · last filed 2023-06-13
- 2023-04-30: Other Investments and Securities, at Cost $100.00K.
- 2023-01-31: Other Investments and Securities, at Cost $300.00K.
- 2022-10-31: Other Investments and Securities, at Cost $300.00K.
- 2022-07-31: Other Investments and Securities, at Cost $500.00K.
| Period end | Other Investments and Securities, at Cost | Other Investments and Securities, at Cost as first filed |
|---|---|---|
| 2023-04-30 | $100.00K 10-Q · filed 2023-06-13 | |
| 2023-01-31 | $300.00K 10-Q · filed 2023-03-14 | |
| 2022-10-31 | $300.00K 10-Q · filed 2022-12-13 | |
| 2022-07-31 | $500.00K 10-K · filed 2022-10-31 | |
| 2022-04-30 | $500.00K 10-Q · filed 2022-06-14 | |
| 2022-01-31 | $500.00K 10-Q · filed 2022-03-17 | |
| 2021-10-31 | $500.00K 10-Q/A · filed 2022-02-28 | |
| 2021-07-31 | $500.00K 10-K · filed 2021-10-18 | |
| 2021-04-30 | $500.00K 10-Q · filed 2021-06-14 | |
| 2020-10-31 | $500.00K 10-Q · filed 2021-03-17 | $2.00M 10-Q · filed 2020-12-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |